Correlation Between Eyenovia and NextCure

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eyenovia and NextCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyenovia and NextCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyenovia and NextCure, you can compare the effects of market volatilities on Eyenovia and NextCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyenovia with a short position of NextCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyenovia and NextCure.

Diversification Opportunities for Eyenovia and NextCure

0.83
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Eyenovia and NextCure is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Eyenovia and NextCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCure and Eyenovia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyenovia are associated (or correlated) with NextCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCure has no effect on the direction of Eyenovia i.e., Eyenovia and NextCure go up and down completely randomly.

Pair Corralation between Eyenovia and NextCure

Given the investment horizon of 90 days Eyenovia is expected to under-perform the NextCure. In addition to that, Eyenovia is 7.3 times more volatile than NextCure. It trades about -0.18 of its total potential returns per unit of risk. NextCure is currently generating about -0.37 per unit of volatility. If you would invest  134.00  in NextCure on September 15, 2024 and sell it today you would lose (26.00) from holding NextCure or give up 19.4% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Eyenovia  vs.  NextCure

 Performance 
       Timeline  
Eyenovia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eyenovia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
NextCure 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NextCure has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Eyenovia and NextCure Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eyenovia and NextCure

The main advantage of trading using opposite Eyenovia and NextCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyenovia position performs unexpectedly, NextCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCure will offset losses from the drop in NextCure's long position.
The idea behind Eyenovia and NextCure pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance